Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
This study has been completed.
Study NCT00020631 Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Radiation Fibrosis
Additional conditions recognized in this trial
Fibrosis
Radiation Pneumonitis
More general conditions related to this trial
Disorders of Environmental Origin
Lung Diseases
Lung Diseases, Interstitial
Pathologic Processes
Radiation Injuries
Respiratory Tract Diseases
Wounds and Injuries
Interventions listed in this trial
pirfenidone
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Antirheumatic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
